Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Squamous Intraepithelial Lesions 2

Interventions

human papillomavirus vaccine, L1 type 16, 18 4Imiquimod 3VGX-3100 2Conization 2Colposcopy 2Blood Specimen Collection 2lime 1hecolin 1Vaginal Smears 1Vaccines, Synthetic 1Spectrometry, Fluorescence 1Polymerase Chain Reaction 1Papillomavirus Vaccines 1Olive Oil 1Mass Screening 1Isotretinoin 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hepatitis A Vaccines 1Fluorouracil 1Fenretinide 1Electroporation 1Cryosurgery 1AKAP13 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Uterine Cervical Dysplasia × VGX-3100 × Clear all
NCT03721978 2024-10-17

REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)

Inovio Pharmaceuticals

Phase 3 Completed
203 enrolled 34 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡